D'ERAMO, Giuseppe
 Distribuzione geografica
Continente #
NA - Nord America 3.438
EU - Europa 1.508
AS - Asia 903
AF - Africa 123
SA - Sud America 25
OC - Oceania 6
Totale 6.003
Nazione #
US - Stati Uniti d'America 3.382
IT - Italia 722
IN - India 417
CN - Cina 324
FI - Finlandia 244
UA - Ucraina 165
SE - Svezia 146
SG - Singapore 127
TG - Togo 107
DE - Germania 52
CA - Canada 46
IE - Irlanda 46
GB - Regno Unito 32
NL - Olanda 19
FR - Francia 17
AR - Argentina 16
AT - Austria 15
KR - Corea 15
BE - Belgio 13
CH - Svizzera 11
MX - Messico 10
IR - Iran 6
SC - Seychelles 6
ZA - Sudafrica 6
PT - Portogallo 5
AU - Australia 4
BG - Bulgaria 4
BR - Brasile 4
CL - Cile 4
HK - Hong Kong 4
RU - Federazione Russa 4
AE - Emirati Arabi Uniti 3
EG - Egitto 3
AL - Albania 2
GR - Grecia 2
HR - Croazia 2
NP - Nepal 2
NZ - Nuova Zelanda 2
PL - Polonia 2
RO - Romania 2
VN - Vietnam 2
AD - Andorra 1
CI - Costa d'Avorio 1
CO - Colombia 1
DK - Danimarca 1
ES - Italia 1
ID - Indonesia 1
MY - Malesia 1
TR - Turchia 1
Totale 6.003
Città #
Chandler 386
Fairfield 344
Princeton 276
Plano 233
Woodbridge 176
Wilmington 170
Ashburn 162
Ann Arbor 131
Beijing 128
Rome 123
Houston 114
Lomé 107
Seattle 107
Cambridge 101
Boston 98
Millbury 85
Andover 66
Des Moines 63
San Diego 59
Jacksonville 57
San Paolo di Civitate 49
Singapore 49
Dublin 46
Norwalk 40
Milan 36
Lawrence 35
Dearborn 33
Toronto 32
Nanjing 28
Kunming 27
San Mateo 27
Bühl 24
Hefei 23
Guangzhou 18
Amsterdam 16
Federal 16
New York 16
Nanchang 15
Vienna 15
Redmond 14
Boardman 13
Helsinki 13
Udine 11
Brussels 10
Chengdu 10
Falls Church 10
Grafing 10
Jinan 10
Redwood City 9
Buffalo 8
London 8
Salerno 8
Shaoxing 8
Fuzhou 7
Ladispoli 7
Marano Di Napoli 7
Ottawa 7
Seocho-gu 7
Torino 7
Brescia 6
Oderzo 6
Shenyang 6
Trieste 6
Venice 6
Fremont 5
Lisbon 5
Mexico City 5
Albenga 4
Baotou 4
Bremen 4
Bussolengo 4
Canegrate 4
Como 4
Figline Valdarno 4
Genova 4
Grammichele 4
Hong Kong 4
Jesi 4
Muizenberg 4
Naples 4
Sofia 4
Staunton 4
Turin 4
Viterbo 4
Bern 3
Cairo 3
Castelnuovo Rangone 3
Catania 3
Chaoyang 3
Dubai 3
Gangnam-gu 3
Harbin 3
Indiana 3
Los Angeles 3
Mannheim 3
Mira 3
Montréal 3
Napoli 3
Ningbo 3
Palermo 3
Totale 3.876
Nome #
Tumore del testicolo a cellule germinali "burned out" 481
Impiego della lefetamina cloridrato (Santenol) nella piccola chirurgia urologica 114
Effects of long-term treatment with the anti-androgen bicalutamide on human testis: An ultrastructural and morphometric study 112
Multidisciplinary team in cancer management 94
MRI-targeted or standard biopsy for prostate-cancer diagnosis 85
Advanced prostatic cancer: Clinical and hormonal response to flutamide in patients pretreated with LHRH analogue and cyproterone acetate 70
LESIONI PRECANCEROSE E GRAY ZONE: ASPETTI CLINICI E PATTERN RM 69
Loss of Renal Function After Retrograde Ureteral Placement of an Allium Stent for Severe Ureteral Stricture 69
DNA ploidy, Gleason score, pathological stage and serum PSA levels as predictors of disease-free survival in C-D1 prostatic cancer patients submitted to radical retropubic prostatectomy 67
Gleason score ≥ 8 prostate adenocarcinoma is associated with higher serum chromogranin A levels also in non metastatic disease. 65
ANDROGENIC AND ANTIANDROGENIC CONTROL ON EPIDERMAL GROWTH-FACTOR, EPIDERMAL GROWTH-FACTOR RECEPTOR, AND ANDROGEN RECEPTOR EXPRESSION IN HUMAN PROSTATE-CANCER CELL-LINE LNCAP 64
Age-adjusted mortality rate and regional distribution for human renal cell carcinoma in Italy between 1969 and 1978. 63
Use of cyclooxygenase-2 inhibitor for prevention of urethral strictures secondary to transurethral resection of the prostate 63
Effects of long term treatment with serenoa repens on the concentrations and regional distribution of androgen and epidermal growth factor in benign prostatic hyperplasia 62
PENILE METASTASIS FROM CARCINOMA OF THE PROSTATE IN A PATIENT WITH HIGH SERUM PSA LEVELS 61
RELATIONSHIP AMONG AGE, PSA AND PROSTATE VOLUME IN MEN WITH LUTS AND IN DIFFERENT GROUPS OF MEN WITH AND WIHTOUT BENIGN AND MALIGNANT PROSTATE DISEASES 57
RELATIONSHIP AMONG SYMPTOMS SCORE,PROSTATE VOLUME AND URINARY FLOW RATES IN 543 PATIENTS WITH AND WIHTOUT BPH 54
EVIDENCE THAT SERENOA-REPENS EXTRACT DISPLAYS AN ANTIESTROGENIC ACTIVITY IN PROSTATIC TISSUE OF BENIGN PROSTATIC HYPERTROPHY PATIENTS 54
Alternative forms of medical treatment in benign prostatic hyperplasia 52
Regional distribution of epidermal growth factor, testosterone and dihydrotestosterone in benign prostatic hyperplasia tissue 52
Cryotherapy for prostate cancer 50
NEW ULTRASENSITIVE ASSAY DEVELOPMENT BY USING MONOCLONAL-ANTIBODIES FOR DETECTING PROSTATE-SPECIFIC ANTIGEN 49
The prognostic value of DNA content in patients with prostatic carcinoma. 49
Zoladex vs. Zoladex plus cyproterone acetate in the treatment of advanced prostatic cancer: A multicenter Italian study 49
Evidence that serenoa repens extract displays an antiestrogenic activity in prostatic tissue of benign prostatic hypertrophy patients. 49
The prognostic value of DNA content in patients with prostatic carcinoma. 45
New ultrasensitive assay development by using monoclonal antibodies for detecting prostate specific antigen 44
Ecografia e citologia urinaria nella diagnosi dei tumori superficiali della vescica. 42
Incidental prostatic carcinoma: Four-year follow-up after treatment with cyproterone acetate 42
Clinical understaging in patients with prostate adenocarcinoma submitted to radical prostatectomy: predictive role of serum chromogranin A. 42
Effect of long-term treatment with Serenoa repens (Permixon) on the concentrations and regional distribution of androgens and epidermal growth factor in benign prostatic hyperplasia 42
Il citoaspirato e la biopsia istologica nella diagnosi del carcinoma prostatico. 41
Anti estrogens and antiandrogens in human benign prostatic hyperplasia 40
C and D1 prostate cancer. 40
Alcuni aspetti di fisiopatologia endocrina della iperplasia prostatica (IP) umana 39
A biochemical mediator of stromal-epithelial interaction:Epidermal Growth Factor levels and stromal epithelial content in different regions of human Benign Prostatic Hyperplasia tissue 37
PHARMACOLOGICAL COMBINATIONS IN THE TREATMENT OF BENIGN PROSTATIC HYPERTROPHY 36
Pathology of BPH. 36
Acinar atrophy and prostatic intraepithelial neoplasia in prostate specimen from radical prostatectomy. 35
Effects of long-term treatment with the anti-androgen bicalutamide on human testis: an ultrastructural and morphometric study 35
Biochemical mediator of stromal-epithelial interaction: Epithelial growth factor levels and stromal epithelial content in different regions of benign prostatic hypertrophy tissue 34
Biochemical and molecular assessment of epidermal growth factor and its receptor in LNCaP cell line following androgen and antiandrogen treatment 34
Which patients with prostate cancer are actually candidates for hormone therapy? 34
Evaluation of causes of obstructive uropathy by MR pyelography 33
Biochemical and molecular assessment of epidermal growth factor and its receptor in LNCaP cell line following androgen and antiandrogen treatment 33
Oral ethinylestradiol in castration resistent prostate cancer: 10 year experience 33
Neoplasia transizionale infiltrante dell'uretra e dei dotti prostatici- uretrocistoprostato-vesciculectomia in blocco 33
Effects of long-term treatment with antiandrogen Casodex on human testis. An ultrastructural and morphometric study. 33
Response of tissue androgen and epidermal growth factor concentrations to the administration of finasteride, flutamide and serenoa repens in patients with benign prostatic hyperplasia 32
A rare case of association of polycystic kidney and hypernephroma 32
A rare case of single metastatis of papillary carcinoma of the excretory tract treated with surgical therapy only 32
Affidabilità dell’ecotomografia nel follow-up delle neoplasie vescicali 32
Androgenic and antiandrogenic control on prostate cancer progression: response to intermittent androgen deprivation (IAD) 32
La fisiopatologia dello stravaso urinoso nella ostruzione acuta della via escretrice 31
PSA as a prognostic factor in prostate cancer. 31
Gleason score >/=8 prostate adenocarcinoma is associated with higher serum cromogranin A levels also in non metastatic disease. 30
High insuline-growth factor I and II and type 1 receptor expression in the periurethral region o human prostatic hyplerplasia tissue 30
Corrispondenza tra interessamento dei margini chirurgici in corso di prostatectomia radicale evidenziati con ecografia ad “immersione” e curva di discesa del Psa. 30
MR pyelography in the evaluation of causes of obstructive uropathy. 29
Approccio farmacologico all’ipertrofia prostatica benigna:razionale dell’utilizzo degli alfa1 bloccanti nell’esperienza clinica. 29
Metastasi orbitaria da carcinoma prostatico: valutazione della risposta alla terapia ormonosoppressiva 29
High insuline-growth factor I and II and type 1 receptor expression in the periurethral region o human prostatic hyplerplasia tissue. 29
Terapia con Flutamide nei pazienti con carcinoma prostatico in stadio avanzato. 29
Segni clinici, stadiazione, randomizzazione e sopravvivenza in 105 pazienti con adenocarcinoma renale. 29
The “dipping” sonography for the evaluation of the surgical margins during radical prostatectomy of patients with intracapsular prostatic cancer. 29
Correlation between serum PSA and intraprostatic concentration of EGF and DHT in patients with BPH 28
Biochemical and molecular assessment of epidermal growth factor and its receptor in LNCaP cell line following androgen and antiandrogen treatment 28
Is medical therapy an expensive way for delaying surgery in BPH patients? 27
Role of prostate specific antigen and its "derivatives" (age-referenced PSA, PSA density, PSA velocity, free/total PSA) in the diagnosis and evaluation of prostate cancer [Ruolo dell'antigene prostatico specifico e dei suoi indici derivati (PSA età-specifico, densità-PSAD, velocità-PSAV, PSA libero-f-PSA) nella diagnosi del carcinoma della prostata] 27
Correlation between epidermal growth factor and steroid receptors in benign prostatic hypertrophy 26
Multidisciplinary team (MDT) in cancer management. 26
Correlazione fra i livelli dell'antigene specifico prostatico e i livelli intratissutali del diidrotestosterone ed epidermal growth factor in pazienti con ipertrofia prostatica benigna 26
Adenocarcinoma renale in rene policistico congenito dell’adulto. Short case: problema oncologico. 26
Plant extracts in BPH 26
Risk-factors in renal cell carcinoma (RCC). 26
Correlation between serum PSA and intraprostatic concentration of EGF and DHT in patients with BPH 26
Influenza della ploidia del DNA, dei livelli di PSA e del Gleason score nella sopravvivenza libera da malattia dopo chirurgia radicale per carcinoma della prostata 25
Right nephrectomy of renal cell carcinoma and excision of omolateral pulmonary metastasis. 25
Esperienza con Flutamide nel trattamento di seconda linea. 25
Zonal distribution of androgens and epidermal growth factor (EGF) in human BPH tissue: responsiveness to flutamide, finasteride and serenoa repens administration 25
Vie di accesso ecografiche nei tumori vescicali 24
Tumore del testicolo a cellule germinali "Burned out". 24
Oncological and functional management in nerve sparing radical prostatectomy: periprostatic neurovascular bundles (NVB) evaluation with magnetic resonance imaging (MRI) and prostate mapping with spectroscopy. 24
Valutazione dei margini chirurgici in pazienti affetti da adenocarcinoma prostatico clinicamente intracapsulare 24
Tumore del testicolo a cellule germinali "Burned out". 24
Treatment with orgotein of induratio penis plastica 24
Analisi multivariata dei fattori prognostici del carcinoma renale 23
Evaluation of causes of obstructive uropathy by pyelography. 23
Biological significance and prognostic implications of cellular DNA content in human renal cell carcinomas. 23
Clinical and hormonal response to flutamide treatment after orchiectomy plus cyproterone acetate in patients with prostatic carcinoma 23
Incidental prostate carcinoma: 4-year follow up following treatment with cyproterone acetate 23
Correlation between grade, cellular ploidy and survival in patients with renal carcinoma stage I according to Robson 23
IPERTROFIA PROSTATICA BENIGNA.ASPETTI ISTOPATOLOGICI ED INQUADRAMENTO CLINICO 22
The role of growth factors and androgen receptors in benign prostatic hyperplasia 22
Carcinoma a cellule renali associato co altri tumori primitivi in organi bersaglio di ormoni steroidei .Influenza della storia riproduttiva e dei fattori ormonali 22
Response of tissue androgen and epidermal growth factor concentrations to the administration of Finasteride,Flutamide and Serenoa Repens in patients with BPH. 22
Renal cell carcinoma (RCC) associated with primary tumors involving different steroid hormone target tissues: Relationship with reproductive and hormone factors 22
Surgery of pulmonary metastases from renal and bladder carcinoma. 22
Influenza degli isoflavonidi ed altri componenti della dieta alimentare nello sviluppo del carcinoma prostatico. 22
New Ultrasensitive assay development by using monoclonal antibodies (McAB) for detecting PSA 22
Totale 4.282
Categoria #
all - tutte 17.470
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 17.470


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019172 0 0 0 0 0 0 0 0 0 0 104 68
2019/2020987 265 13 8 24 53 143 173 99 66 76 51 16
2020/2021341 32 25 13 70 15 21 10 46 21 51 25 12
2021/20221.807 11 122 137 68 269 18 40 154 128 185 219 456
2022/20231.562 463 290 49 149 144 168 27 66 125 16 45 20
2023/2024530 62 73 14 34 25 27 51 28 7 133 76 0
Totale 6.157